Recently, the results of the “2024 Forbes China Top 50 AI Tech Companies” selection, initiated by Forbes China, were officially announced. The evaluation process spanned seven months and drew from multiple information sources to provide a comprehensive, multidimensional assessment of each company’s overall strength and performance in the field of artificial intelligence.

The selection was based on in-depth research and analysis across various aspects of the AI industry, including technological advancement, application scenarios, industrial ecosystem, and market scale. Companies were evaluated across six key dimensions: technological innovation, market performance, real-world impact, application outcomes, sustainability potential, and team culture. Synyi AI stood out for its leading technologies and practical applications in AI, earning a place on the prestigious 2024 Forbes China Top 50 AI Tech Companies list — a strong testament to the company’s technical strength and steady growth.

As a nationally certified high-tech enterprise, Synyi AI is dedicated to integrating artificial intelligence and big data technologies with healthcare application scenarios. The company currently serves over 400 medical institutions and has extensive experience in regional platforms and medical consortiums. Throughout its development, it has earned broad industry recognition.

To date, Synyi AI has received more than 200 world-class and national-level awards and honors, holds over 200 patents and software copyrights, and has published over 100 academic papers.

Synyi AI remains committed to driving technological innovation, continuously advancing the digital transformation of the healthcare sector, and contributing to the creation of a more efficient, intelligent, and secure healthcare service system for the broader public.